Comparison of two double labeling techniques to measure cell cycle kinetics in myeloid leukemias.
Five patients with acute myeloid leukemia (AML) received a one hour infusion of iododeoxyuridine (IUdR) 100 mg/M2 to label S-phase cells in vivo. The aspirate was labeled in vitro either with tritiated thymidine (3HTdr) or bromodeoxyuridine (BrdU) to measure the duration of S-phase (Ts). The mean Ts using 3HTdr (Ts1) was 15.9h (13.1-19.8h) and using BrdU (Ts2) was 17.1h (14.5-20.6h). Total cell cycle time (Tc) ranged between 44.7h to 158.8h using Ts1 and 54.0h to 170.5h using Ts2. Based on this close approximation between the results, we confirm the reliability of the newly developed method that relies purely on immunohistochemical reaction.
Yousuf
N
N
Barrett Cancer Center, Cincinnati, Ohio 45267.
Yanik
G A
GA
George
B A
BA
Masterson
M
M
Mazewski
C M
CM
White
L M
LM
Miller
M A
MA
Lampkin
B C
BC
Raza
A
A
D001973:Bromodeoxyuridine; D002453:Cell Cycle; D006801:Humans; D007065:Idoxuridine; D007150:Immunohistochemistry; D015470:Leukemia, Myeloid, Acute / Q000473:pathology*; D008722:Methods; D014316:Tritium
D014316:Tritium; D001973:Bromodeoxyuridine; D007065:Idoxuridine